Gagnon Securities LLC Profound Medical Corp. Transaction History

Gagnon Securities LLC

$474 Million
Q3 2024

A detailed history of Gagnon Securities LLC transactions in Profound Medical Corp. stock. As of the latest transaction made, Gagnon Securities LLC holds 1,467,247 shares of PROF stock, worth $10.2 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares

1,467,247

Previous 1,508,521 2.74%

Holding current value

$10.2 Million

Previous $12.7 Million 7.72%

% of portfolio

2.46%

Previous 2.99%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$7.47 - $11.18 $308,316 - $461,443	-41,274 Reduced 2.74%	1,467,247 $11.7 Million
Q2 2024 Aug 14, 2024	SELL	$7.25 - $9.07 $148,741 - $186,080	-20,516 Reduced 1.34%	1,508,521 $12.7 Million
Q1 2024 May 13, 2024	SELL	$7.3 - $9.46 $91,534 - $118,618	-12,539 Reduced 0.81%	1,529,037 $13 Million
Q4 2023 Feb 14, 2024	SELL	$7.85 - $11.18 $318,631 - $453,796	-40,590 Reduced 2.57%	1,541,576 $13.1 Million
Q3 2023 Nov 14, 2023	SELL	$7.91 - $13.27 $181,724 - $304,864	-22,974 Reduced 1.43%	1,582,166 $16.1 Million
Q2 2023 Aug 08, 2023	SELL	$9.27 - $14.88 $1.07 Million - $1.72 Million	-115,424 Reduced 6.71%	1,605,140 $20.9 Million
Q1 2023 Apr 10, 2023	SELL	$8.85 - $13.27 $510,122 - $764,896	-57,641 Reduced 3.24%	1,720,564 $16 Million
Q4 2022 Feb 07, 2023	BUY	$3.18 - $10.91 $36,093 - $123,828	11,350 Added 0.64%	1,778,205 $19.4 Million
Q3 2022 Nov 14, 2022	BUY	$3.99 - $9.3 $1.75 Million - $4.09 Million	439,323 Added 33.09%	1,766,855 $7.13 Million
Q2 2022 Aug 01, 2022	BUY	$6.34 - $9.53 $20,268 - $30,467	3,197 Added 0.24%	1,327,532 $9.68 Million
Q1 2022 May 09, 2022	BUY	$8.16 - $11.33 $2.02 Million - $2.8 Million	246,978 Added 22.92%	1,324,335 $11.9 Million
Q4 2021 Feb 08, 2022	BUY	$10.38 - $15.2 $11.2 Million - $16.4 Million	1,077,357 New	1,077,357 $12.1 Million
Q3 2021 Nov 12, 2021	SELL	$13.6 - $17.88 $10.9 Million - $14.3 Million	-800,845 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$16.0 - $20.59 $367,280 - $472,643	22,955 Added 2.95%	800,845 $13.1 Million
Q1 2021 May 14, 2021	SELL	$19.16 - $28.09 $829,742 - $1.22 Million	-43,306 Reduced 5.27%	777,890 $15.7 Million
Q4 2020 Feb 12, 2021	BUY	$16.4 - $22.9 $683,273 - $954,082	41,663 Added 5.34%	821,196 $16.9 Million
Q3 2020 Nov 12, 2020	BUY	$14.05 - $18.13 $671,842 - $866,940	47,818 Added 6.54%	779,533 $13.8 Million
Q2 2020 Aug 13, 2020	SELL	$9.41 - $16.94 $340,745 - $613,414	-36,211 Reduced 4.72%	731,715 $12.4 Million
Q1 2020 May 11, 2020	BUY	$6.88 - $19.7 $489,278 - $1.4 Million	71,116 Added 10.21%	767,926 $7.48 Million
Q4 2019 Feb 14, 2020	BUY	$6.4 - $11.95 $4.46 Million - $8.33 Million	696,810 New	696,810 $7.63 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

8.93M

Call Options Held

1.2K

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $146M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.

Account

Gagnon Securities LLC Profound Medical Corp. Transaction History